Clinical trial

Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients-

NCT04843813

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-03-26

PhaseNA

Study timeline

Study start (actual)2021-03-26Date precision: day

Registry last updated2021-04-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

LuteinDIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

University of Illinois at Urbana-Champaignlead sponsor

Division of Nutritional Sciences, University of Illinois at Urbana-Champaigncollaborator

National Institutes of Health (NIH)collaborator

Mapped research locations

UrbanaIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04843813 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.